- Gaston Naessens 714X
- Naessens 714X
For Patients & Caregivers
Tell your healthcare providers about any dietary supplements you’re taking, such as herbs, vitamins, minerals, and natural or home remedies. This will help them manage your care and keep you safe.
How It Works
There is no scientific evidence to support the use of 714X for cancer prevention or treatment.
714X is a chemical mixture that was developed by Gaston Naessens, a French biologist from Canada. Although several claims have been made for 714X, such as cancer regression and revitalizing the immune system, the U.S. Food and Drug Administration found that 714X contains relatively inactive ingredients: 94% water, 5% nitrate, and tiny amounts of sodium, chloride, and camphor. Whereas such a mixture may not be harmful to the body, there are no data to show that 714X can treat cancer or AIDS.
For Healthcare Professionals
A proprietary product developed in the 1960s, 714X is used to prevent and treat cancer, AIDS, lupus, fibromyalgia, and chronic fatigue syndrome. It is promoted as a sterile, isotonic formulation that contains nitrates (~5%), ammonium (~1.4%), and camphor (0.01%) (1). It is illegal in the United States and is available only in Canada under the Compassionate Use Program (2).
714X is injected intra-lymphatically in the groin area daily for 21 days followed by three treatment-free days. This cycle is repeated at least three times. Inhalation therapy is used concomitantly for patients with head and neck or lung cancer. Injection site reactions, including redness and soreness, may occur (1) (2). 714X has not been evaluated for any of the proposed claims.
Mechanism of Action
Developed by Gaston Naessens, 714X is said to help disease regression, revitalize the immune system, and support host defense mechanisms. Promoters claim that camphor has selective affinity for cancer cells, while nitrate fulfills cancer cells’ nitrogen requirement, thereby protecting immune cells. The nitrogen-enriched camphor supposedly antagonizes the secretion of cocancerogenic K factor by cancer cells (1) (2). There are no data to support the above mechanisms of action nor benefits of this product.